Assessment of the Efficacy of Certolizumab Pegol in the Maintenance of Response for the Treatment of Crohn's Disease

被引：0
|
作者：
Lee, Scott D.
Ko, Cynthia W.
Wahbeh, Ghassan
Cullinan, Cory
Etter, Scott
Sinanan, Mika N.
Wheat, Chelle
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S282 / S282
页数：1
相关论文
共 50 条
  • [31] Pharmakokinetics of Certolizumab Pegol Induction in Crohn's Disease
    Wolf, Douglas C.
    Wolf, Christine
    GASTROENTEROLOGY, 2015, 148 (04) : S867 - S868
  • [32] Certolizumab pegol for induction of remission in Crohn's disease
    Yamazaki, Hajime
    So, Ryuhei
    Matsuoka, Katsuyoshi
    Kobayashi, Taku
    Shinzaki, Shinichiro
    Matsuura, Minoru
    Okabayashi, Shinji
    Kataoka, Yuki
    Tsujimoto, Yasushi
    Furukawa, Toshi A.
    Watanabe, Norio
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (08):
  • [33] Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegol
    Feagan, B. G.
    Hanauer, S. B.
    Coteur, G.
    Schreiber, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (10) : 1143 - 1151
  • [34] Superior efficacy of certolizumab pegol in early Crohn's disease is independent of Crp status
    Schreiber, Stefan
    Hanauer, Stephen B.
    Lichtenstein, Gary R.
    Sandborn, William J.
    GASTROENTEROLOGY, 2007, 132 (04) : A510 - A511
  • [35] Certolizumab pegol for the treatment of Crohn's disease is approved now for a using in the USA
    不详
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2008, 46 (08): : 855 - 855
  • [36] Certolizumab pegol (CDP870) for treatment of Crohn's disease - Reply
    Schreiber, S
    GASTROENTEROLOGY, 2006, 130 (01) : 286 - 286
  • [37] Efficacy of Certolizumab Pegol Induction and Maintenance Therapy in Patients With Crohn's Disease Not in Remission Following Active or Placebo Induction
    Sandborn, William J.
    Younes, Ziad H.
    Pierre-Louis, Bosny
    D'Haens, Geert R.
    GASTROENTEROLOGY, 2012, 142 (05) : S565 - S565
  • [38] Editorial: long-term safety and efficacy of certolizumab pegol for Crohn's disease
    Cesarini, M.
    Danese, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (10) : 1243 - 1243
  • [39] Maintenance therapy with Certolizumab Pegol for Crohn's disease (vol 357, pg 239, 2007)
    Schreiber, S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (13): : 1357 - 1357
  • [40] Estimation of induction and maintenance costs of infliximab, adalimumab and certolizumab pegol in managing Crohn's disease
    Feagan, Brian
    Tan, Seng
    Malone, Daniel
    Hinojosa, Joaquin
    Brown, Martin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S392 - S392
12345